Compugen

Compugen is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery, therapeutic and diagnostic. Compugen provides innovative products and services to pharmaceutical, biotechnology and other life science organizations through corporate solutions and to individual life scientists through the LabOnWeb.com Web site. In addition, the company is commercializing the genes and proteins that are discovered through the company's drug discovery division.

Contact Details: 7 Center Drive, Suite 7 Jamesburg NJ 08831 United States of America Tel: 609 655 5105 Fax: 609 655 5114 Email: info@cgen.com WWW: www.cgen.com

Loading...

Recent Publications by Compugen:
Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept. Blocking conformational changes in biologically active proteins holds...	9th October, 2009	Compugen Ltd.,	Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13797-801. Epub 2009 Aug 5. DOI Direct Link
Large-scale analysis of secondary structure changes in proteins suggests a role for disorder-to-order transitions in nucleotide binding proteins. Conformational changes in proteins often involve secondary structure...	14th August, 2009	Compugen Ltd., 72 Pinchas Rosen, Tel Aviv, 69512, Israel.	Proteins. 2009 Jul 7. DOI Direct Link
Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor. In a screening effort based on algorithmic predictions for novel...	23rd May, 2009		Ann N Y Acad Sci. 2009 Apr;1160:78-86. DOI Direct Link
A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects. Activation of the formyl-peptide receptor-like (FPRL) 1 pathway has...	24th February, 2009	Compugen Ltd., 72 Pinchas Rosen St., Tel Aviv, Israel 69512.	J Pharmacol Exp Ther. 2009 Feb;328(2):426-34. Epub 2008 Nov 20. DOI Direct Link
Discovery and validation of novel peptide agonists for G-protein-coupled receptors. G-protein-coupled receptors (GPCRs) represent an important group of...	20th February, 2009	Compugen Limited, 72 Pinchas Rosen St., Tel Aviv 69512, Israel.	J Biol Chem. 2008 Dec 12;283(50):34643-9. Epub 2008 Oct 9. DOI Direct Link
→View more Compugen research publications.

Press Releases on Compugen:
Northbank Communications Strengthens PR Team with the Appointment of Dr	1st May, 2004	Northbank	Northbank Communications Strengthens PR Team with the Appointment of Dr Douglas Pretsell as Account Manager London, Manchester, Munich, 13th May 2004 … Northbank
Compugen Announces Licensing of its Z4000 System for Proteomic Research	1st February, 2002	Compugen	Compugen Announces Licensing of its Z4000 System for Proteomic Research to Organon and Procter & Gamble Tel Aviv, Israel –

BioNews Results for Compugen:
Medical News: Compugen Announces Discovery Of Genetic Biomarker For Predisposition To Type 2 Diabetes	BioFind:  Nov 11 2009 2:04PM Matching: compugen
Compugen Announces Discovery Of Genetic Biomarker For Predisposition To Type 2 Diabetes	Medical News Today:  Nov 11 2009 12:42PM Matching: compugen
Compugen Reports Discovery of Genetic Biomarker for Predisposition to Type 2 Diabetes	Individual.com:  Nov 11 2009 6:16AM Matching: compugen
Compugen Reports Discovery of Genetic Biomarker for Predisposition to Type 2 Diabetes	TradingMarkets:  Nov 11 2009 6:06AM Matching: compugen
Compugen Announces Preeclampsia Biomarker Collaboration	Bionity.com:  Nov 10 2009 11:04PM Matching: compugen
Promote your company here: BioNewsCast - Press Release Distribution	→View more Compugen news.

Compugen Patents:
US Patent No.	Title
7601692	MCP-1 splice variants and methods of using same
6625545	Method and apparatus for mRNA assembly
6720182	Alternative splice variants of CD40
6740516	Nucleic acid and amino acid sequences
6783954	VEGF nucleic acid and amino acid sequences
→View more Compugen patents.

Compugen (CGEN) Financial information Links from Barchart
CGEN Quote from from Barchart.com
CGEN Chart from from Barchart.com
CGEN Profile from from Barchart.com
CGEN Opinion from from Barchart.com
→View more Compugen finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 598 times since April 2007, the link to the organisation's website has been followed 104 times

Recent Search Terms used to find this page: patenta compugen cgen | compugen microarray | compugen | compugen | compugen cgen | Peptides modulating conformational changes in secretion chaperones From in silico design to preclinical proof of concept. | compugen | Pinchas Rosen Street map of street | compugen u.s. patent | compugen microarray | .

Search for more companies in Jamesburg

Search for more companies in NJ

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Compugen